CE Certification Obtained for In-Vitro Diagnostic Rapid Test Portfolio; ISO 9001 and ISO 13485 Renewed

On August 17, 2015, CHIL successfully obtained CE certification from a European Notified Body for its in-vitro diagnostic product portfolio, including high-risk group assays HIVAb, HCVAb, and HBsAg, as well as Chlamydia and PSA Rapid Tests.

On the same date, the company also completed the renewal of its ISO 9001 and ISO 13485 certifications, confirming continued compliance with internationally recognized quality management and medical device standards.

Together, these achievements reinforced CHIL’s regulatory credentials and validated the quality and conformity of its products for international markets.